High Court's Sorrell Ruling Yet To Transform Drug Marketing

The U.S. Supreme Court's 2011 ruling in Sorrell v. IMS Health set the stage for looser limits on off-label promotion by drugmakers, but experts say the upshot for Big Pharma has been hard to gauge, as the U.S. Food and Drug Administration continues ...read more

  • Tags: